Non-alcoholic fatty liver disease (NAFLD), the most common chronic liver diseases, arise
from non-alcoholic fatty liver (NAFL) characterized by excessive fat accumulation as …

Nonalcoholic fatty liver disease (NAFLD) is a major cause of chronic liver disease,
characterized by hepatic fat accumulation and possible development of inflammation …

Nonalcoholic fatty liver disease (NAFLD) spectrum disorders affect approximately 1 billion
individuals worldwide. However, the drivers of progressive steatohepatitis remain …

Nonalcoholic fatty liver disease (NAFLD) has become the most common chronic liver
disease worldwide and also become an emerging risk factor for liver-related complications …

Liver plays a central role in the biogenesis of major metabolites including glucose, fatty
acids, and cholesterol. Increased incidence of obesity in the modern society promotes …

Nonalcoholic fatty liver disease (NAFLD) is a highly prevalent, and potentially morbid,
disease that affects one-third of the US population. Normal liver safely accommodates lipid …

Weight loss by ketogenic diet (KD) has gained popularity in management of nonalcoholic
fatty liver disease (NAFLD). KD rapidly reverses NAFLD and insulin resistance despite …

Mitochondrial adaptation during non-alcoholic fatty liver disease (NAFLD) include
remodeling of ketogenic flux and sustained tricarboxylic acid (TCA) cycle activity, which are …

While several molecular targets are under consideration, mechanistic underpinnings of the
transition from uncomplicated nonalcoholic fatty liver disease (NAFLD) to nonalcoholic …

Non-alcoholic steatohepatitis (NASH), a cause of cirrhosis and hepatocellular carcinoma, is
characterized by fatty infiltration of the liver, inflammation, hepatocellular damage and …